Literature DB >> 19218878

Erythropoietin-receptor gene regulation in neuronal cells.

Iwona Wallach1, Juan Zhang, Anika Hartmann, Frank K H van Landeghem, Anna Ivanova, Martin Klar, Christof Dame.   

Abstract

Because erythropoietin (Epo) is intensively studied as neuroprotective agent, Epo receptor (EpoR) regulation in neurons is of particular interest. Herein, we investigated molecular mechanisms of EpoR regulation in neuronal cells including the role of GATA transcription factors. First, developmental downregulation of EpoR expression in murine brain was observed. A differential expression pattern of the Gata factors was found in these specimens as well as in murine adult neural stem cells (NSC) and primary rat neurons, astrocytes, and microglia. Human SH-SY5Y cells served as a model to analyze EpoR regulation. In vitro binding of GATA-2, -3, and -4 to the 5'-flanking region was demonstrated. In reporter gene assays, the activity of a region containing two GATA binding sites was significantly induced when these GATA factors were overexpressed. However, GATA factors alone did not affect endogenous EpoR expression. Importantly, EpoR transcripts have doubled under hypoxia. Furthermore, we analyzed the methylation pattern close to the GATA motifs. Indeed, demethylation with 5-Aza-2'-deoxycytidine (Aza) resulted in upregulation of EpoR mRNA. Additionally, several CpGs were mostly nonmethylated in SH-SY5Y cells, but methylated in specific regions of the human adult brain. Thus, methylation may be involved in developmental EpoR downregulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218878     DOI: 10.1203/PDR.0b013e31819ea3b8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia.

Authors:  Anne Kästner; Sabrina Grube; Ahmed El-Kordi; Beata Stepniak; Heidi Friedrichs; Derya Sargin; Judith Schwitulla; Martin Begemann; Ina Giegling; Kamilla W Miskowiak; Swetlana Sperling; Kathrin Hannke; Anna Ramin; Ralf Heinrich; Olaf Gefeller; Klaus-Armin Nave; Dan Rujescu; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 2.  Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

Authors:  Vijayeta Rangarajan; Sandra E Juul
Journal:  Pediatr Neurol       Date:  2014-06-24       Impact factor: 3.372

3.  Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.

Authors:  Yiting Cao; Justin D Lathia; Christine E Eyler; Qiulian Wu; Zhizhong Li; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Cancer       Date:  2010-01-01

4.  The Differential Effects of Erythropoietin Exposure to Oxidative Stress on Microglia and Astrocytes in vitro.

Authors:  Praneeti Pathipati; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2017-05-17       Impact factor: 2.984

Review 5.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

6.  Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.

Authors:  Christopher M Traudt; Sandra E Juul
Journal:  Methods Mol Biol       Date:  2013

7.  Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Ailing Huang; Shixiang Wen; Bing Liao; Stanley H Appel
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

8.  GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes.

Authors:  V Hoene; M Fischer; A Ivanova; T Wallach; F Berthold; C Dame
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

9.  Changes in the Expression of Transcription Factors Involved in Modulating the Expression of EPO-R in Activated Human CD4-Positive Lymphocytes.

Authors:  Katarzyna A Lisowska; Joanna E Frackowiak; Anna Mikosik; Jacek M Witkowski
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Erythropoietin in brain development and beyond.

Authors:  Mawadda Alnaeeli; Li Wang; Barbora Piknova; Heather Rogers; Xiaoxia Li; Constance Tom Noguchi
Journal:  Anat Res Int       Date:  2012-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.